please read this MSB press release about surrogate endpoint for CHF treatment:
https://investorsmedia.mesoblast.com/static-files/4e3907df-6f04-476b-b7e2-eef7a7029d8a
In my opinion, Accelerating the Approval for the ischemic class II/III HFrEF2 patients is now a real possibility.
The share price shall skyrocket if this happens.
please read this MSB press release about surrogate endpoint for...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.72 |
Change
-0.075(4.19%) |
Mkt cap ! $2.191B | |||
| Open | High | Low | Value | Volume |
| $1.82 | $1.84 | $1.71 | $5.879M | 3.318M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 22542 | $1.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.72 | 18087 | 22 |
View Market Depth
| Last trade - 12.08pm 19/06/2025 (20 minute delay) ? |
| MSB (ASX) Chart |